4.8650.93% ( +0.045 )
Delay Closed: Nov 2, 16:08:15Current ValuationThe current P/E ratio is 33.04, within the reasonable range, cheaper than 52.87% of the time in the past 1 years, and the industry ranks 29/52, the industry Median 6.70.
33.04xP/E
HK$4.87Stock price
HK$0.15Earnings per share
33.04xP/E
Stock priceHK$4.87Earnings per shareHK$0.15
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 33.89x
- Typical range
- 29.04x–38.00x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.70x
09182736
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.70x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01276HKHENGRUI PHARMA | 32.29x | 17.44% | HK$334.18B |
01177HKSBP GROUP | 33.04x | 111.35% | HK$90.89B |
06996HKANTENGENE-B | 31.37x | 246.19% | HK$1.94B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
